Dicerna Pharmaceuticals OverviewDicerna Pharmaceuticals Net Income
Profitability analysis for DRNA.
Quarterly Net Income
-$17.07M
↑ 21.86% YoY
As of Sep 2021
Annual Net Income (TTM)
-$124.44M
↓ 7.43% YoY
Trailing 12 months ending Sep 2021
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...